Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
SanDisk has enjoyed a dramatic rally, but traders are wrestling with whether the rally can run further as memory cycl...
Intel stock climbs about 5% after word that the company is in talks to acquire AI accelerator startup Tenstorrent, re...
Bitcoin’s resistance stall could presage a broader correction as on-chain metrics darken and momentum wanes. Analysts...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
Bitcoin has moved sharply after its peak, creating a dilemma for investors. This guide breaks down what bitcoin after...
States are racing to regulate home equity investment products as the market grows, with Maine enacting strict licensi...
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
A concrete retirement deadline hinges on two numbers: the day-one portfolio balance and MAGI staying below ACA subsid...
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...